Pacira Pharmaceuticals (PCRX) is a specialty pharmaceutical company focused on the development, commercialization and manufacture of pharmaceutical products, based on its DepoFoam drug delivery technology, for use in hospitals and ambulatory surgery centers. This stock is trading up 12% to $7.72 in recent trading.
Today's Range: $7.08-$7.8252-week Range: $6.16-$15.34 Volume: 2,043,000 Three-Month Average Volume: 168,986 This stock is spiking nicely today after the company announced the pricing of a public offering of 7 million shares of common stock at a price of $6.50 per share. >>10 Biotech Stocks Loved and Hated by the Pros From a technical standpoint, this stock is still trading well below its 50-day moving average of $9.23 despite the large move up today. Yes, volume is very strong, but that volume has much to do with the public offering. I would only consider getting interested in this stock from the long side if it can manage to move back above its 50-day moving average of $9.23 on high volume.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV